NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 159 filers reported holding NUVALENT INC in Q4 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $787,047 | +539.1% | 10,375 | +532.6% | 0.01% | +333.3% |
Q1 2024 | $123,148 | -46.3% | 1,640 | -47.4% | 0.00% | 0.0% |
Q4 2023 | $229,527 | +676.5% | 3,119 | +385.1% | 0.00% | +200.0% |
Q3 2023 | $29,559 | +53.7% | 643 | +41.0% | 0.00% | 0.0% |
Q2 2023 | $19,229 | +7979.4% | 456 | -95.0% | 0.00% | -87.5% |
Q1 2023 | $238 | +852.0% | 9,107 | +981.6% | 0.01% | +700.0% |
Q4 2022 | $25 | -100.0% | 842 | -88.3% | 0.00% | -50.0% |
Q3 2022 | $140,000 | -25.1% | 7,171 | -47.9% | 0.00% | -50.0% |
Q2 2022 | $187,000 | +1770.0% | 13,768 | +1770.7% | 0.00% | – |
Q1 2022 | $10,000 | -73.0% | 736 | -61.8% | 0.00% | -100.0% |
Q4 2021 | $37,000 | +131.2% | 1,928 | +164.5% | 0.00% | – |
Q3 2021 | $16,000 | – | 729 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $843,021,482 | 18.00% |
Fairmount Funds Management LLC | 2,884,492 | $121,639,028 | 17.15% |
Bain Capital Life Sciences Investors, LLC | 3,577,267 | $150,853,349 | 15.54% |
COMMODORE CAPITAL LP | 1,150,000 | $48,495,500 | 5.45% |
Paradigm Biocapital Advisors LP | 1,120,465 | $47,250,009 | 3.65% |
Perceptive Advisors | 2,194,821 | $92,555,602 | 2.68% |
Boxer Capital, LLC | 1,210,192 | $51,034 | 2.37% |
Ikarian Capital, LLC | 272,752 | $11,501,952 | 1.83% |
SILVERARC CAPITAL MANAGEMENT, LLC | 115,067 | $4,852,375 | 1.50% |
HighVista Strategies LLC | 72,298 | $3,048,807 | 1.40% |